Literature DB >> 6342243

Changes in BCG strains.

T W Osborn.   

Abstract

BCG originated from a virulent bovine strain of the tubercle bacillus after prolonged serial subculture on a potato medium. Since attenuation was achieved, the BCG strain has been distributed to a large number of centres where BCG vaccine is produced. Many of these production laboratories have maintained their BCG lines by continuing serial transfers, but have employed a variety of media for this purpose, and have produced BCG vaccine by a variety of techniques. Distinct differences have developed between some of the daughter strains of BCG, but the mechanism through which these changes have occurred has not been clear. In recent years methods have been developed which have enabled changes taking place within some BCG strains during experimental serial subculture to be monitored. In this survey the relationship of the changes observed to the different techniques employed for the maintenance of BCG lines and for the preparation of vaccine is considered. It is suggested that selection of minority populations within BCG strains noted during experimental studies may provide an analogy with the mechanism through which the original attenuation of the virulent bovine strain was brought about. The relevance of small-scale laboratory investigations to full-scale production procedures is also discussed, and finally some additional measures that might be taken to minimise changes in BCG strains are proposed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342243     DOI: 10.1016/0041-3879(83)90044-2

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  15 in total

1.  Observing bacterial activity interferometrically.

Authors:  D Faragó Jardim; R Batista Santiago Neto; R R P Machado; F M Aarestrup; J P R F de Mendonça; B Lesche
Journal:  Eur Biophys J       Date:  2003-03-22       Impact factor: 1.733

2.  Evaluation of spoligotyping in a study of the transmission of Mycobacterium tuberculosis.

Authors:  Y O Goguet de la Salmonière; H M Li; G Torrea; A Bunschoten; J van Embden; B Gicquel
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  History of BCG Vaccine.

Authors:  Simona Luca; Traian Mihaescu
Journal:  Maedica (Bucur)       Date:  2013-03

4.  Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex.

Authors:  H G Wiker; K Sletten; S Nagai; M Harboe
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety.

Authors:  J B Milstien; J J Gibson
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

6.  Genetic identification of Mycobacterium bovis BCG by restriction fragment length polymorphism analysis of the direct-repeat region.

Authors:  S T Howard; A Laszlo; W M Johnson
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.

Authors:  M R Lagranderie; A M Balazuc; E Deriaud; C D Leclerc; M Gheorghiu
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

8.  A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.

Authors:  M A Behr; B G Schroeder; J N Brinkman; R A Slayden; C E Barry
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

9.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Authors:  M Harboe; T Oettinger; H G Wiker; I Rosenkrands; P Andersen
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

10.  Novel genome polymorphisms in BCG vaccine strains and impact on efficacy.

Authors:  Andrea S Leung; Vanessa Tran; Zuowei Wu; Xuping Yu; David C Alexander; George Fu Gao; Baoli Zhu; Jun Liu
Journal:  BMC Genomics       Date:  2008-09-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.